Cell therapy weekly: world’s first successful transplant of human embryonic stem cell-derived hepatocytes for liver disorder performed in Japan

Written by RegMedNet

This week: Kite (CA, USA) has received approval to implement a Marketing Authorization variation for Yescarta®, which allows for end-to-end manufacturing and renders Kite’s newest European manufacturing facility in Amsterdam fully operational, and in a new study, a team led by researchers from the University of Rio de Janeiro (Brazil) have investigated the ability of magnetic targeting to help retain mice mesenchymal stromal cells (MSCs) in the lungs of mice with silicosis. The news highlights: World’s first successful transplant of human embryonic stem cell-derived hepatocytes for liver disorder performed in Japan EMA approval allows new CAR-T therapy manufacturing facility to...

To view the full article, please register now for access

It's completely free